Tenofovir dipivuroxime enrutabine adduct CAS 1962114-98-2

Description

Compared with other compounds in its class, the molecular weight of 778.70 g/mol gives Tenofovir dipivuroxime enrutabine adduct distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Tenofovir dipivuroxime enrutabine adduct (CAS 1962114-98-2), a certified reference material (molecular formula C28H40FN8O13PS, MW 778.70 g/mol) for analytical method development and quality control.

The molecular framework of Tenofovir dipivuroxime enrutabine adduct (C28H40FN8O13PS) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a phosphate ester group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures Tenofovir dipivuroxime enrutabine adduct under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com